Navigation Links
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
Date:3/18/2008

FRANKLIN LAKES, N.J., March 18 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it has elected John R. Considine as Vice Chairman and Chief Financial Officer of BD and a member of the Board of Directors, effective immediately. Mr. Considine is currently Senior Executive Vice President and Chief Financial Officer of BD. With his election, the BD Board consists of 14 members, all of whom are independent with the exception of Mr. Considine and Edward J. Ludwig, Chairman, President and Chief Executive Officer.

Mr. Considine, 57, joined BD in May 2000 as Executive Vice President and Chief Financial Officer, after spending 17 years at Wyeth in various financial roles including Senior Vice President - Finance of the corporation. He is currently responsible for worldwide finance, information technology, manufacturing, quality and supply chain operations. Mr. Considine will stand for election at BD's Annual Meeting of Shareholders in 2009. He is expected to serve on the Board of Directors until his planned retirement from BD following the 2010 Annual Meeting.

"I look forward to working closely with John over the next two years to further our strategy of increasing revenue growth through innovation, complemented by driving operating effectiveness and productivity," said Edward J. Ludwig, Chairman, President and Chief Executive Officer. "John has proven his value to the Company, at both the strategic and operational levels, and he will bring unique skills and depth of knowledge to the Board. His contributions will be instrumental in paving the path for BD's continued success, and I look forward to working with him in his expanded role."

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit http://www.bd.com.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hillenbrand Industries Announces Formal Board Approval of Separation by Means of Share Distribution and Details for Completion
2. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
3. Weight Watchers Announces Election of Kim Roy to Board of Directors
4. Previously Disclosed Changes in Board Composition of NightHawk Radiology Holdings, Inc. Prompt Notice of Noncompliance from the Nasdaq Global Market
5. CardioDynamics Board of Directors Proposes Reverse Split 1:7 of Companys Shares
6. Alexander M. Cutler Nominated for Election to DuPont Board of Directors
7. Stuart Altman, Ph.D. Joins INSPIRIS Board of Directors
8. Hospital Caregivers Unveil Billboards Calling for Improved Patient Care, Quality Jobs at Community Medical Centers
9. First-Ever National Board Certification(R) for Americas Health Educators Arrives
10. Ventas Appoints James D. Shelton and Robert D. Reed to Board
11. Former Federal Reserve Chairman Paul Volcker To Join Board of Directors of Still River Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... Emergency rooms provide emergency care to stabilize critical health issues, but emergency ... emergencies at risk of losing a tooth or their smiles. Dr. Marine Martirosyan, ... emergencies include:, , Avulsed or knocked-out teeth , ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... bring together more than 200 of the country’s top healthcare executives to share ... “The true benefit of the Forum is the provider-centric perspective, experience, expertise and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... digital self-scheduling readily available to physicians. The integration will enable Allscripts users ... select appointments via Everseat’s free mobile app. , The partnership gives Everseat substantial ...
(Date:2/10/2016)... , ... February 10, 2016 , ... The recreational use ... enthusiasts in the state still face a lot of restrictions as to where they ... intended for private, personal use” and that cannabis “may not be consumed openly or ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016 CSI Specialty Group (CSI) expanded its ... the Specialty Pharmacy Podcast. A free, weekly show, the ... real-world education, discussion and context amongst specialty pharmacy peers ... --> The Specialty Pharmacy Podcast, hosted by ... Group Suzette DiMascio, CHE, CMCE, CPC, is available for ...
(Date:2/10/2016)... Switzerland and SAN DIEGO ... , Inc., a global leader in viral gene therapy ... therapy treatments for congestive heart failure and other chronic ... develop a scalable manufacturing process and produce cGMP-grade RT-100 ... trials. --> --> ...
(Date:2/10/2016)... Feb. 10, 2016 Urologix, the market leader ... of Benign Prostatic Hyperplasia (BPH), announces new private ownership ... , a medical device industry veteran of more than ... Liability Company.  Plymouth, Minn. ... Cooled ThermoTherapy™ and Prostiva® RF Therapy, will continue to ...
Breaking Medicine Technology: